Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: A clinicopathological case report

Movement Disorders

Volumn 19, Issue 8, 2004, Pages 973-977

  Lezcano, Elena ^a   Gómez Esteban, Juan C ^a   Zarranz, Juan J ^a   Alcaraz, Rafael ^b   Atarés, Begoña ^c   Bilbao, Gaizka ^d   Garibi, Jesús ^d   Lambarri, Imanol ^d  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Phorensic Medicine Institute   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

Author keywords

Deep brain stimulation; Multiple system atrophy; Parkinson's disease; Subthalamic nucleus

Indexed keywords

ENTACAPONE; LEVODOPA; OLANZAPINE; SELEGILINE;

ADULT; ARTICLE; AUTOPSY; BRAIN DEGENERATION; BRAIN DEPTH STIMULATION; BRAIN WEIGHT; CASE REPORT; CEREBELLUM ATROPHY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DYSKINESIA; DYSTONIA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIPARKINSON AGENTS; BENZAMIDES; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION THERAPY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEVODOPA; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PYRROLIDINES; RETROSPECTIVE STUDIES; STAINING AND LABELING; SUBTHALAMIC NUCLEUS; SYNUCLEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 4444223568     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20108     Document Type: Article

References (26)

1. Lantos PL. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 1998;57:1099-1111.
2. Burn DJ, Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol Pathol 2001;54:419-426.
3. Osaki Y. Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59:1486-1491.
4. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
5. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991:18: 275-278.
6. Hughes AJ. Clinicopathological aspects of Parkinson's disease. Eur Neurol 1997;38(Suppl. 2):13-20.
7. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125(Pt 4):861-870.
8. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17(Suppl. 3):S94-S101.
9. Defer GL. [Surgical treatment: inclusion criteria]. Rev Neurol (Paris) 2000; 156(Suppl. 2, Pt 2):251-256.
10. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
11. Rajput AH, Rozdilsky B, Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology 1991;41:1298-1299.
12. Tison F, Yekhlef F. Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord 2002; 17:701-709.
13. Albanese A, Colosimo C, Bentivoglio AR, Fenici R. Melillo G, Tonali P. Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;59:144-151.
14. Reiche W, Grundmann M, Huber G. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome]. Radiologe 1995;35:838-843.
15. Knable MB, Jones DW, Coppola R, et al. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease. J Nucl Med 1995;36:1216-1225.
16. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
17. Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72: 300-303.
18. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of' multiple system atrophy. An analysis of 100 cases. Brain 1994; 117(Pt 4):835-845.
19. Chaudhuri KR. Autonomic dysfunction in movement disorders. Curr Opin Neurol 2001;14:505-511.
20. Magalhaes M, Wenning GK, Daniel SE, Quinn NP. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease - a retrospective comparison. Acta Neurol Scand 1995:91:98-102.
21. Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy - parkinsonism. Report of four cases. J Neurosurg 2003:98:882-887.
22. Berciano J. Valldeoriola F, Ferrer I, et al. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002;17:812-816.
23. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003;61:247-249.
24. Henderson JM, Pell M, O'Sullivan DJ, et al. Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease. Mov Disord 2002;17:133-137.
25. Haberler C, Alesch F, Mazal PR, et al. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Ann Neurol 2000;48:372-376.
26. Gonzalez AM, Berciano J, Figols J, Pazos A, Pascual J. Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration. Brain Res 2000;852:228-232.